Dr. Jacks is a professor of biology and Director of the Koch Institute at MIT, as well as an investigator at Howard Hughes Medical Institute. He graduated magna cum laude with Highest Honors in biology from Harvard University in 1983 and earned a Ph.D. in biochemistry from the University of Calif...
Dr. Jacks is a professor of biology and Director of the Koch Institute at MIT, as well as an investigator at Howard Hughes Medical Institute. He graduated magna cum laude with Highest Honors in biology from Harvard University in 1983 and earned a Ph.D. in biochemistry from the University of California, San Francisco in 1988. He then went on to do postdoctoral research at MIT in the Whitehead Institute in the lab of Robert Weinberg. He was named an assistant professor at MIT in 1992 and associate professor with tenure in 1997. In 2000, he was promoted to full professor standing. He also served on the Board of Scientific Advisors of the National Cancer Institute, is a past president of the American Association of Cancer Research, sits on the board of directors at Thermo Fisher Scientific and Aveo Pharmaceuticals, and is a member of the Scientific Advisory Board at T2Biosystems and at Epizyme. Dr. Jacks was named the 2005 Simon M. Shubitz Lecturer and Award recipient, and shared the 2005 Paul Marks Prize for Cancer Research awarded by Memorial Sloan-Kettering Cancer Center.